Role of potassium channels in relaxations of canine middle cerebral arteries induced by nitric oxide donors

Stroke

Volumn 28, Issue 6, 1997, Pages 1264-1271

  Onoue, Hisashi ^a   Katusic, Zvonimir S ^a  

^a MAYO CLINIC   (United States)

Author keywords

Cerebral arteries; Cyclic GMP; Dogs; Nitric oxide; Vasodilation

Indexed keywords

4 AMINOPYRIDINE; 8 BROMO CYCLIC AMP; BARIUM CHLORIDE; CALCIUM CHANNEL BLOCKING AGENT; CHARYBDOTOXIN; CYCLIC GMP; DILTIAZEM; GLIBENCLAMIDE; LINSIDOMINE; NITRIC OXIDE DONOR; NITROPRUSSIDE SODIUM; POTASSIUM CHANNEL; POTASSIUM CHANNEL BLOCKING AGENT; ZAPRINAST;

ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOG; MIDDLE CEREBRAL ARTERY; MUSCLE ISOMETRIC CONTRACTION; NONHUMAN; PRIORITY JOURNAL; RADIOIMMUNOASSAY; SMOOTH MUSCLE RELAXATION; VASODILATATION;

EID: 0030955924     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.28.6.1264     Document Type: Article

References (42)

1. Furchgott RF. Role of endothelium in responses of vascular smooth muscle. Circ Res. 1983;53:557-573.
2. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev. 1991;43: 109-142.
3. Ignarro LJ, Kadowitz PJ. The pharmacological and physiological role of cyclic GMP in vascular smooth muscle relaxation. Annu Rev Pharmacol Toxicol. 1985;25:171-191.
4. Brayden JE. Membrane hyperpolarization is a mechanism of endothelium-dependent cerebral vasodilation. Am J Physiol. 1990;259: H668-H673.
5. Nelson MT, Quayle JM. Physiological roles and properties of potassium channels in arterial muscle. Am J Physiol. 1995;268: C799-C822.
6. Cohen RA, Vanhoutte PM. Endothelium-dependent hyperpolarization: beyond nitric oxide and cyclic GMP. Circulation. 1995;92: 3337-3349.
7. + channels in vascular smooth muscle cells. Proc Natl Acad Sci USA. 1988;85:9360-9364.
8. Robertson BE, Schubert R, Hescheler J, Nelson MT. cGMP-dependent protein kinase activates Ca-activated K channels in cerebral artery smooth muscle cells. Am J Physiol. 1993;265: C299-C303.
9. Archer SL, Huang JMC, Hampl V, Nelson DP, Shultz PJ, Weir EK. Nitric oxide and cGMP cause vasorelaxation by activation of a charybdotoxin-sensitive K channel by cGMP-dependent protein kinase. Proc Natl Acad Sci U S A. 1994;91:7583-7587.
10. Bolotina VM, Najibi S, Palacino JJ, Pagano PJ, Cohen RA. Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle. Nature. 1994;368:850-853.
11. Kontos HA. Nitric oxide and nitrosothiols in cerebrovascular and neuronal regulation. Stroke. 1993;24(suppl I):I-155-I-158.
12. Faraci FM, Brian JE. Nitric oxide and the cerebral circulation. Stroke. 1994;25:692-703.
13. Kim P, Schini VB, Sundt TM, Vanhoutte PM. Reduced production of cGMP underlies the loss of endothelium-dependent relaxations in the canine basilar artery after subarachnoid hemorrhage. Circ Res. 1992;70:248-256.
14. Katusic ZS, Milde JH, Cosentino F, Mitrovic BS. Subarachnoid hemorrhage and endothelial L-arginine pathway in small brain stem arteries in dogs. Stroke. 1993;24:392-399.
15. Onoue H, Kaito N, Akiyama M, Tomii M, Tokudome S, Abe T. Altered reactivity of human cerebral arteries after subarachnoid hemorrhage. J Neurosurg. 1995;83:510-515.
16. Edwards FR, Hirst GDS, Silverberg GD. Inward rectification in rat cerebral arterioles: involvement of potassium ions in autoregulation. J Physiol. 1988;404:455-466.
17. + channels in the relaxant responses of dog middle cerebral artery to cromakalim. J Pharmacol Exp Ther. 1990;255:818-825.
18. + current in freshly dispersed cerebral arterial muscle cells. Pflugers Arch. 1991;418:292-296.
19. + channels in the resting state of cerebral, coronary and mesenteric arteries of the dog. J Pharmacol Exp Ther. 1993;267:1277-1285.
20. Kitazono T, Faraci FM, Taguchi H, Heistad DD. Role of potassium channels in cerebral blood vessels. Stroke. 1995;26:1713-1723.
21. Katusic ZS, Shepherd JT, Vanhoutte PM. Vasopressin causes endothelium-dependent relaxations of the canine basilar artery. Circ Res. 1984;55:575-579.
22. Katusic ZS, Shepherd JT, Vanhoutte PM. Endothelium-dependent contraction to stretch in canine basilar arteries. Am J Physiol. 1987; 252:H671-H673.
23. 1-vasopressinergic receptors. J Pharmacol Exp Ther. 1986; 236:166-170.
24. + channels from mammalian skeletal muscle. Nature. 1985;313:316-318.
25. + channels. J Gen Physiol. 1988;91: 317-333.
26. Gimenez-Gallego G, Navia MA, Reuben JP, Katz GM, Kaczorowski GJ, Garcia ML. Purification, sequence, and model structure of charybdotoxin, a potent selective inhibitor of calcium-activated potassium channels. Proc Natl Acad Sci U S A. 1988;85:3329-3333.
27. + channels in cerebral vasodilatation induced by increases in cyclic GMP and cyclic AMP in the rat. Stroke. 1996;27:1603-1608.
28. + channels in arterial and intestinal smooth muscle cell membranes. Pflugers Arch. 1985;403:120-127.
29. + currents in smooth muscle cells from rat resistance-sized cerebral arteries. Am J Physiol. 1993;265:C1363-C1370.
30. Wellman GC, Bevan JA. Barium inhibits the endothelium-dependent component of flow but not acetylcholine-induced relaxation in isolated rabbit cerebral arteries. J Pharmacol Exp Ther. 1995;274:47-53.
31. Bonev AD, Nelson MT. ATP-sensitive potassium channels in smooth muscle cells from guinea pig urinary bladder. Am J Physiol. 1993;264:C1190-C1200.
32. + current in single smooth muscle cells of the guinea-pig portal vein. Pflugers Arch. 1992;421:22-25.
33. Bean BP. Pharmacology and electrophysiology of ATP-activated ion channels. Trends Pharmacol Sci. 1992;13:87-90.
34. Edwards G, Weston AH. The pharmacology of ATP-sensitive potassium channels. Annu Rev Pharmacol Toxicol. 1993;33: 597-637.
35. Okabe K, Kitamura K, Kuriyama H. Features of 4-aminopyridine sensitive outward current observed in single smooth muscle cells from rat aorta. Pflugers Arch. 1987;409:561-569.
36. + currents in smooth muscle cells from cerebral arteries. Am J Physiol. 1994;267:C1589-C1597.
37. Koh SD, Campbell JD, Carl A, Sanders KM. Nitric oxide activates multiple potassium channels in canine colonie smooth muscle. J Physiol. 1995;489:735-743.
38. Hogg N, Darley-Usmar VM, Wilson MT, Moncada S. Production of hydroxyl radicals from the simultaneous generation of superoxide and nitric oxide. Biochem J. 1992;281:419-424.
39. Michenfelder JD. Cyanide release from sodium nitroprusside in the dog. Anesthesiology. 1977;46:196-201.
40. Harris AL, Lemp BM, Bentley RG, Perrone MH, Hamel LT, Silver PJ. Phosphodiesterase isozyme inhibition and the potentiation by zaprinast of endothelium-derived relaxing factor and guanylate cyclase stimulating agents in vascular smooth muscle. J Pharmacol Exp Ther. 1989;249:394-400.
41. Dundore RL, Clas DM, Wheeler LT, Habeeb PG, Bode DC, Buchholz RA, Silver PJ, Pagani ED. Zaprinast increases cyclic GMP levels in plasma and in aortic tissue of rats. Eur J Pharmacol. 1993;249:293-297.
42. Takase Y, Saeki T, Fujimoto M, Saito I. Cyclic GMP phosphodiesterase inhibitors, I: the discovery of a novel potent inhibitor, 4-((3,4-(methylenedioxy)benzyl)amino)-6,7,8-trimethoxyquinazoline. J Med Chem. 1993;36:3765-3770.